AbbVie Strikes Deal to Acquire Allergan for About $63 Billion

AbbVie to buy Allergan in $63 billion drug deal | CNN Business

AbbVie announced it will buy Allergan for $63 billion, combining the companies behind Humira and Botox and creating yet another pharmaceutical behemoth.

Consumer groups, unions urge caution on $63 billion AbbVie deal ...

... it to consider blocking drugmaker AbbVie Inc's planned $63 billion purchase of Botox maker Allergan Plc .

Botox Maker Allergan Is Sold to AbbVie in $63 Billion Deal

The drugmaker AbbVie said on Tuesday that it planned to buy Allergan, the maker of Botox, for about $63 billion, in one of the biggest mergers in the health ...

AbbVie wins U.S. antitrust OK to buy Allergan | Crain's Chicago ...

The FTC signed off on the $63 billion takeover of the Botox maker after the companies agreed to resolve competition concerns by selling two ...

AbbVie makes $63 billion bid for Botox maker Allergan

Allergan was long based in Orange County until it was acquired in 2014 by Actavis Plc for $66 billion.

AbbVie Wins US Antitrust OK To Buy Allergan - PYMNTS.com

... Allergan, clearing the last hurdle from competition regulators to the $63 billion deal. The Federal Trade Commission said late Tuesday that ...

AbbVie's $63 Billion Mistake | Cafepharma Message Boards

via AbbVie (NYSE: ABBV) announced this morning its intention to acquire Irish drugmaker Allergan (NYSE: AGN) in a stock-and-cash deal for ...

Analysts rip into AbbVie, Allergan's $63B deal, citing culture clash ...

AbbVie made a major splash Tuesday with its proposed $63 billion buyout of Allergan that'll create a top-5 pharma giant. But analysts and investors were hardly ...

Expert Q&A on Health Care Mergers and Acquisitions

AbbVie Inc.'s proposed $63 billion acquisition of Allergan plc is one of the largest health care mergers announced ... The AbbVie/Allergan deal came about for ...

US regulator clears AbbVie's $63bn deal for Allergan - Financial Times

A US competition regulator has given the go-ahead for US drugmaker AbbVie to buy Allergan, which makes Botox, in a $63bn deal.

Allergan - Wikipedia

In June 2019, U.S. pharmaceutical company AbbVie announced it had reached an agreement to acquire Allergan for $63 billion. The merged company would be ...

AbbVie makes US$63B bid for Botox maker Allergan - CTV News

The specialty drug company AbbVie will spend $63 billion to acquire Allergan, the maker of Botox and other cosmetic treatments.

AbbVie makes $63B bid for Botox maker Allergan | AP News

Facing competition for the world's top-selling drug, AbbVie will spend about $63 billion to buy Botox maker Allergan as it attempts to spur ...

AbbVie makes $63B bid for Botox maker Allergan - Boston Herald

Facing competition for the world's top-selling drug, AbbVie is jumping on this year's pharmaceutical merger bandwagon with a $63 billion bid ...

AbbVie makes $63B bid for Botox maker Allergan - CityNews Calgary

AbbVie is buying Botox maker Allergan in a cash-and-stock deal valued at around $63 billion. The maker of the blockbuster immune disorder treatment Humira said ...

"Bloomberg Businessweek" AbbVie Strikes $63 Billion Deal for ...

"Bloomberg Businessweek" AbbVie Strikes $63 Billion Deal for Botox Maker Allergan, U.S. Set to Delay China Tariffs, Protecting Burls (Podcast Episode 2019) ...

AbbVie looks to sell $5 billion portfolio - Crain's Chicago Business

The drugmaker is in talks to divest its women's health unit, which it picked up last year through its $63 billion Allergan acquisition.

Big Pharma deals top $200 billion so far in 2019 - Axios

The pharmaceutical industry has already shelled out more than $200 billion for acquisitions ... AbbVie's $63 billion buyout offer for Allergan.

AbbVie Inc - The New York Times

Botox Maker Allergan Is Sold to AbbVie in $63 Billion Deal ... The transaction would give AbbVie a potent source of popular treatments as it faces the loss of ...

Betting big on Botox: Rival company buys drug maker for $63bn

AbbVie Inc. has agreed to pay $63 billion for rival drugmaker Allergan Plc, the latest merger in an industry where some of the biggest ...